Shanghai Labway Clinical Laboratory Co (301060.SZ) Stock Price

Shanghai Labway Clinical Laboratory Co Price

SZSE·CLOSED
10.52
​
Market closed

Revenue has compounded at 10.0% per year over the past 12 years to 1.45 B CNY. Earnings per share have grown at 24.7% per year over the last 9 years. Shanghai Labway Clinical Laboratory Co's net margin stands at -2.1%, down from 11.5% several years earlier. Shanghai Labway Clinical Laboratory Co currently offers a dividend yield of about 1.90%.

Shanghai Labway Clinical Laboratory Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Labway Clinical Laboratory Co business model & stock analysis

Shanghai Labway Clinical Laboratory Co., Ltd. generates revenue through medical and pathological examination services, including pathological diagnosis, molecular examination, biochemical examination, immune examination, microbial examination, clinical basic examination, and physical and chemical examination. The company also sells in vitro diagnostic instruments, reagents, and related accessories and consumables. Its primary customers are healthcare providers and medical institutions requiring diagnostic services and diagnostic products. The business segments are medical testing services and in vitro diagnostic product sales. The company's medical testing services cater to hospitals and clinics seeking comprehensive diagnostic solutions, while the in vitro diagnostic product sales target healthcare facilities needing equipment and supplies for laboratory operations. These services and products are provided to clients across China, focusing on the healthcare sector's demand for accurate and timely diagnostic capabilities. Shanghai Labway's revenue streams are derived from both service fees for examinations and sales of diagnostic instruments and reagents. The company's offerings align with the growing need for advanced medical diagnostics in China's expanding healthcare market, serving a broad client base within the medical industry.

Frequently asked questions about Shanghai Labway Clinical Laboratory Co

Converted at the current exchange rate, the Shanghai Labway Clinical Laboratory Co share trades at 1.41 EUR (10.52 CNY).

The Shanghai Labway Clinical Laboratory Co share (301060.SZ) is listed on 1 stock exchanges, including: Shenzhen (301060.SZ).

The revenue cannot currently be calculated for Shanghai Labway Clinical Laboratory Co.

The profit cannot currently be calculated for Shanghai Labway Clinical Laboratory Co.

The P/E ratio cannot be calculated for Shanghai Labway Clinical Laboratory Co at the moment.

The P/S cannot be calculated for Shanghai Labway Clinical Laboratory Co currently.

The Eulerpool Quality Score for Shanghai Labway Clinical Laboratory Co is 2/10.

The ISIN of Shanghai Labway Clinical Laboratory Co is CNE100004RG8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Shanghai Labway Clinical Laboratory Co is 301060.SZ. The ticker symbol is used to trade Shanghai Labway Clinical Laboratory Co shares on the stock exchange.

Fair ValueTerminal
9.99 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
771,050.75 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website labway.cn
Country
Currency
CNY
Initial public offering
Sep 13, 2021
ISIN
CNE100004RG8
Cusip
Y768JM106
Market capitalization
4.26 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
122.07
P/B Ratio
2.75
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.86 %
Dividend
Dividend yield
1.90 %
Payout Ratio
-259.23 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
1 year
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
10.00 %
Last updated Nov 3, 2026, 3:41 AM

Shanghai Labway Clinical Laboratory Co Peer Group

Shanghai Labway Clinical Laboratory Co Ticker

SHZ · 301060.SZ

Shanghai Labway Clinical Laboratory Co FIGI

301060:CH · BBG00VYXM541301060:CS · BBG00VYXM569301060:C2 · BBG017ZPKLZ2